Fundraising FoxBiokine
Jerusalem, IL · 1 known investors
Find your way into Biokine
Sign up to see every warm intro you have to Biokine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biokine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
Founders & leadership
AP
Amnon PeledCEO/CSO
SC
Simone CabillyChief Scientist
Investors · 1
Frequently asked questions
- What does Biokine do?
- BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
- Who founded Biokine?
- Biokine was founded by Amnon Peled.
- Who are Biokine's investors?
- Biokine's investors include Clal Biotechnology Industries.
- Where is Biokine headquartered?
- Biokine is headquartered in Jerusalem, IL.